However, when CYLD was knocked down, BTKis could not inhibit NFκB activation, which suggested that BTKis down-regulated NFκB signaling pathway was CYLD dependent in non-GCB-DLBCL (Fig. 3g, h). Here, NFKB1 is linked to diffuse large B-cell lymphoma.